National Bank of Canada
FBIO icon

National Bank of Canada’s Fortress Biotech FBIO Stock Holding History

National Bank of Canada’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24
Closed -$8.78K – 3040
2025
Q4 		$8.78K Sell
24
-231
-91% -$658 ﹤0.01% 2339
2025
Q3 		$94.2K Buy
255
+148
+138% +$374 ﹤0.01% 1778
2025
Q2 		$19.9K Buy
+107
New +$185 ﹤0.01% 2179

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

National Bank of Canada's FBIO Position: Q1 2026 in Review

National Bank of Canada sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 2,400 shares — an estimated $8.78K sold.

National Bank of Canada first reported a position in FBIO in Q2 2025 and held it in 3 quarters. The position peaked at $94.2K in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • National Bank of Canada reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 2,400 Fortress Biotech shares in Q1 2026, an estimated $8.78K.
  • National Bank of Canada first reported a position in Fortress Biotech in Q2 2025 and held it in 3 quarters.
  • National Bank of Canada's Fortress Biotech position peaked at $94.2K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.